Acetyl-Histone H3 (Lys23) Antibody (Rabbit mAb) [E10E19]

CatNo: F7964

    Application: Reactivity:
    • Lane 1: HeLa, Lane 2: HeLa (Trichostatin A, 500 ng/ml, 4 h)
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:20%
    転写条件(ウェット): 200 mA, 60 min 0.22 μm PVDF 膜の使用をお勧めします。

    使用情報

    Dilution
    1:1000
    1:2000
    1:800
    Application
    WB, IF, ChIP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    15 kDa 15 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール HeLa cells (Trichostatin A, 500 ng/ml, 4 h); NIH/3T3 cells (Trichostatin A, 500 ng/ml, 4 h)
    ネガティブコントロール NIH/3T3 cells; Hela cells

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 20%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.22 µm PVDF membrane is recommended )Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 60 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use primary antibody dilution buffer to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IF
    Experimental Protocol:
     
    Sample Preparation
    1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use.
    2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine.
    3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time.
    4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval.
     
    Fixation
    1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes.
    2. Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Permeabilization
    1.Add a detergent such as 0.1–0.3% Triton X-100 to the sample and incubate at room temperature for 10–20 minutes.
    (Note: This step is only required for intracellular antigens. For antigens expressed on the cell membrane, this step is unnecessary.)
    Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Blocking
    Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.)
    Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background.
     
    Immunofluorescence Staining (Day 1)
    1. Remove the blocking solution and add the diluted primary antibody.
    2. Incubate the sample in a humidified chamber at 4°C overnight.
     
    Immunofluorescence Staining (Day 2)
    1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time.
    2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours.
    3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time.
    4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes.
    5. Wash with PBST for 3 times, 5 minutes each time.
     
    Mounting
    1. Mount the sample with an anti-fade mounting medium.
    2. Allow the slide to dry at room temperature overnight in the dark.
    3. Store the slide in a slide storage box at 4°C, protected from light.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    Acetyl-Histone H3 (Lys23) Antibody (Rabbit mAb) [E10E19] detects endogenous levels of total Histone H3 protein only when it is acetylated at Lys23.
    タンパク質の局在
    染色体、ヌクレオソームコア、細胞核
    Uniprot ID
    P68431
    Clone
    E10E19
    Synonym(s)
    H3FA, HIST1H3A, H3C2, H3FL, HIST1H3B, H3C3, H3FC HIST1H3C, H3C4, H3FB, HIST1H3D, H3C6, H3FD, H3C1, Histone H3.1, Histone H3/a, Histone H3/b, Histone H3/c, Histone H3/j, Histone H3/k, Histone H3/l, H3K23ac
    Background
    Acetyl-histone H3 (Lys23), often denoted H3K23ac, is a specific post-translational modification on the N‑terminal tail of histone H3 generated by histone lysine acetyltransferases and removed by histone deacetylases, and it contributes to the broader epigenetic program that regulates chromatin structure and gene transcription. Histone H3 carries a globular core domain and an extended tail with multiple modifiable lysine residues, including Lys4, 9, 14, 18, 23, 27, 36 and 56, and acetylation at these positions neutralizes the positive charge of the lysine side chain, reducing electrostatic interactions between histone tails and the DNA backbone and weakening internucleosomal contacts, which promotes a more open chromatin configuration. Acetylation at Lys23 fits into this general mechanism, contributing to relaxation of chromatin and facilitating access of transcriptional machinery to DNA by allowing DNA-binding proteins, including transcription factors and coactivators, to engage their target sequences within nucleosomal regions more efficiently. Acetylated lysine residues on histone H3, including H3K23ac, also create recognition sites for reader proteins containing bromodomains or YEATS domains; these readers recruit additional transcriptional regulators, chromatin remodelers or coactivator complexes to acetylated nucleosomes, integrating H3 tail acetylation into multistep signaling cascades that reinforce transcriptional activation. Within epigenetic histone H3 pathways, H3K23ac participates alongside other acetyl marks in coordinating nuclear organization and chromatin domain states, acting as part of combinatorial PTM patterns that distinguish active promoters, enhancers and transcriptionally engaged gene bodies from repressed regions. In cancer, global changes in histone H3 acetylation, including shifts in tail acetylation, associate with altered gene expression, and dysregulated acetylation contributes to oncogenic signaling by modifying accessibility at loci controlling proliferation, apoptosis and DNA repair; histone acetylation levels, as assessed by site-specific antibodies such as anti–acetyl-H3K23, have been explored as prognostic indicators and as pharmacodynamic readouts for HDAC inhibitor therapy. At a structural level, H3K23ac marks can be monitored with modification-specific antibodies that recognize histone H3 only when Lys23 is acetylated and do not cross-react with other acetylated lysines, providing tools for chromatin immunoprecipitation, immunohistochemistry or western blotting to map or quantify H3K23ac distribution across genomes and tissues.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください